These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 27486164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.
    Greve AM, Bang CN, Berg RM, Egstrup K, Rossebø AB, Boman K, Nienaber CA, Ray S, Gohlke-Baerwolf C, Nielsen OW, Okin PM, Devereux RB, Køber L, Wachtell K.
    Int J Cardiol; 2015 Feb 01; 180():122-8. PubMed ID: 25438232
    [Abstract] [Full Text] [Related]

  • 6. Higher Acceleration/Ejection Time Ratio Predicts Impaired Outcome in Aortic Valve Stenosis.
    Einarsen E, Cramariuc D, Bahlmann E, Midtbo H, Chambers JB, Gerdts E.
    Circ Cardiovasc Imaging; 2021 Jan 01; 14(1):e011467. PubMed ID: 33461302
    [Abstract] [Full Text] [Related]

  • 7. Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis.
    Gerdts E, Rossebø AB, Pedersen TR, Cioffi G, Lønnebakken MT, Cramariuc D, Rogge BP, Devereux RB.
    Circ Cardiovasc Imaging; 2015 Nov 01; 8(11):e003644; discussion e003644. PubMed ID: 26489804
    [Abstract] [Full Text] [Related]

  • 8. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy).
    Lund BP, Gohlke-Bärwolf C, Cramariuc D, Rossebø AB, Rieck AE, Gerdts E.
    Am J Cardiol; 2010 May 15; 105(10):1456-60. PubMed ID: 20451694
    [Abstract] [Full Text] [Related]

  • 9. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.
    Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R.
    Am J Cardiol; 2007 Apr 01; 99(7):970-3. PubMed ID: 17398194
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study.
    Bang CN, Dalsgaard M, Greve AM, Køber L, Gohlke-Baerwolf C, Ray S, Rossebø AB, Egstrup K, Wachtell K.
    Int J Cardiol; 2013 Oct 03; 168(3):2322-7. PubMed ID: 23416018
    [Abstract] [Full Text] [Related]

  • 12. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.
    Rieck ÅE, Cramariuc D, Boman K, Gohlke-Bärwolf C, Staal EM, Lønnebakken MT, Rossebø AB, Gerdts E.
    Hypertension; 2012 Jul 03; 60(1):90-7. PubMed ID: 22647889
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.
    Bang CN, Greve AM, Boman K, Egstrup K, Gohlke-Baerwolf C, Køber L, Nienaber CA, Ray S, Rossebø AB, Wachtell K.
    Am Heart J; 2012 Apr 03; 163(4):690-6. PubMed ID: 22520536
    [Abstract] [Full Text] [Related]

  • 17. Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial).
    Rieck AE, Gerdts E, Lønnebakken MT, Bahlmann E, Cioffi G, Gohlke-Bärwolf C, Ray S, Cramariuc D.
    Cardiovasc Ultrasound; 2012 Nov 05; 10():43. PubMed ID: 23126645
    [Abstract] [Full Text] [Related]

  • 18. Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial.
    Green A, Ramey DR, Emneus M, Iachina M, Stavem K, Bolin K, McNally R, Busch-Sørensen M, Willenheimer R, Egstrup K, Kesäniemi YA, Ray S, Basta N, Kent C, Pedersen TR.
    Am J Cardiol; 2014 Nov 15; 114(10):1518-22. PubMed ID: 25267716
    [Abstract] [Full Text] [Related]

  • 19. Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Nienaber CA, Ray S, Egstrup K, Pedersen TR, Køber L, Willenheimer R, Wachtell K.
    Int J Cardiol; 2013 Jun 05; 166(1):72-6. PubMed ID: 21996417
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).
    Greve AM, Dalsgaard M, Bang CN, Egstrup K, Rossebø AB, Boman K, Cramariuc D, Nienaber CA, Ray S, Gohlke-Baerwolf C, Okin PM, Devereux RB, Køber L, Wachtell K.
    Am J Cardiol; 2014 Sep 01; 114(5):751-6. PubMed ID: 25048345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.